1. Home
  2. RMD vs AME Comparison

RMD vs AME Comparison

Compare RMD & AME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMD
  • AME
  • Stock Information
  • Founded
  • RMD 1989
  • AME 1930
  • Country
  • RMD United States
  • AME United States
  • Employees
  • RMD N/A
  • AME N/A
  • Industry
  • RMD Medical/Dental Instruments
  • AME Industrial Machinery/Components
  • Sector
  • RMD Health Care
  • AME Industrials
  • Exchange
  • RMD Nasdaq
  • AME Nasdaq
  • Market Cap
  • RMD 36.7B
  • AME 41.7B
  • IPO Year
  • RMD 1995
  • AME N/A
  • Fundamental
  • Price
  • RMD $254.41
  • AME $180.94
  • Analyst Decision
  • RMD Buy
  • AME Buy
  • Analyst Count
  • RMD 12
  • AME 8
  • Target Price
  • RMD $259.40
  • AME $200.14
  • AVG Volume (30 Days)
  • RMD 748.6K
  • AME 1.3M
  • Earning Date
  • RMD 07-31-2025
  • AME 07-31-2025
  • Dividend Yield
  • RMD 0.82%
  • AME 0.69%
  • EPS Growth
  • RMD 37.08
  • AME 7.39
  • EPS
  • RMD 8.91
  • AME 6.11
  • Revenue
  • RMD $5,021,529,000.00
  • AME $6,936,971,000.00
  • Revenue This Year
  • RMD $10.37
  • AME $2.56
  • Revenue Next Year
  • RMD $7.77
  • AME $4.65
  • P/E Ratio
  • RMD $28.96
  • AME $29.62
  • Revenue Growth
  • RMD 9.54
  • AME 2.98
  • 52 Week Low
  • RMD $195.00
  • AME $145.02
  • 52 Week High
  • RMD $263.05
  • AME $198.33
  • Technical
  • Relative Strength Index (RSI)
  • RMD 52.85
  • AME 53.29
  • Support Level
  • RMD $251.40
  • AME $180.09
  • Resistance Level
  • RMD $261.08
  • AME $183.68
  • Average True Range (ATR)
  • RMD 4.21
  • AME 2.49
  • MACD
  • RMD -0.51
  • AME -0.06
  • Stochastic Oscillator
  • RMD 34.28
  • AME 65.35

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

About AME AMETEK Inc.

Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.

Share on Social Networks: